Maxidex (Dexamethasone)

Dexamethasone binds to glucocorticoid receptors inside ocular cells, altering gene expression to suppress inflammatory pathways. This reduces the activity of enzymes such as phospholipase A2 and COX‑2, leading to lower production of prostaglandins and leukotrienes, which in turn diminishes swelling and immune cell infiltration in the eye.

The dosing regimen for Maxidex is determined by the prescribing ophthalmologist based on the specific condition, severity and patient response. The prescriber will provide instructions on the number of drops, frequency and duration of therapy, which should be followed exactly as written.

Safety data for Maxidex in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant. Healthcare providers will assess the individual situation and may recommend alternative treatments when appropriate.

To request Maxidex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Maxidex (dexamethasone) is a potent corticosteroid often compared with prednisolone acetate eye drops. Dexamethasone generally has a stronger anti‑inflammatory effect per drop, which may allow for a lower dosing frequency, but both share similar safety profiles and require monitoring of intra‑ocular pressure during prolonged use.

Maxidex should be stored at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed when not in use and retain it in its original packaging. Do not freeze the solution, and discard any product that appears discolored or contains particles.

Maxidex is applied as an eye drop. The patient should wash hands, tilt the head back, pull down the lower eyelid to create a small pocket, and place the prescribed number of drops into the pocket without touching the tip of the bottle to the eye or surrounding tissues. Close the eye gently and blink to spread the medication.

Serious risks include secondary ocular infections, cataract formation, increased intra‑ocular pressure that can lead to glaucoma, severe allergic reactions, corneal ulceration and systemic adrenal suppression with extensive use. Patients should be monitored regularly for these complications, especially during long‑term therapy.

Maxidex is contraindicated in patients with known hypersensitivity to dexamethasone or any component of the formulation. It should also be avoided in individuals with active ocular infections such as viral or fungal keratitis, unless specifically directed by a specialist, because the steroid can exacerbate these conditions.